Search - tctmd.com

Displaying 141 - 160 of 276

Sort: Relevancy | Date

News Daily News

DES Linked With Lower In-Hospital Mortality Than BMS for All PCI Indications

Todd Neale

October 03, 2014

Presentation TCT 2014

Antirestenotic Efficacy in the Treatment of In-Stent Restenosis: A Comparison of Two Paclitaxel Drug-Eluting Balloons With Different Coatings

Presenter: Todd J. Brinton, Ian T. Meredith, Greg L. Kaluza, Freek Nijhoff

September 16, 2014

Presentation TCT 2014

A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: One Year Results of the PATENT-C First-in-Human Trial

Presenter: Bruno Scheller

September 16, 2014

Presentation TCT 2014

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Presenter: James Min

September 16, 2014

Presentation TCT 2014

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

Presenter: John A. Bittl, Tullio Palmerini, Joo Myung Lee, MD

September 15, 2014

Presentation TCT 2014

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso

September 14, 2014

Presentation TCT 2014

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Yelin Zhao

September 13, 2014

Presentation TCT 2014

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Fernando Alfonso

September 13, 2014

Presentation TCT 2014

Approach to In-Stent Restenosis in 2014: DCB or DES?

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Robert A. Byrne

September 13, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton

September 13, 2014

Presentation TCT 2014

How Did I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Alejandro D Fernandez

September 13, 2014

Presentation TCT 2014

How Would I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Eric Van Belle

September 13, 2014

Presentation TCT 2014

Case #2: A Challenging Restenosis Lesion

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Alejandro D Fernandez

September 13, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton

September 13, 2014

Presentation TCT 2014

How Did I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Jacques Berland

September 13, 2014

Presentation TCT 2014

How Would I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Miguel A Larribau

September 13, 2014

Presentation TCT 2014

Case #1: Restenosis in an Unusual Venous Bypass Bifurcated Lesion

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Jacques Berland

September 13, 2014

News Daily News

El Impacto Clínico del Fracaso del SLF Depende del Timing

L.A. McKeown

August 07, 2014

News Daily News

Clinical Impact of DES Failure Depends on Timing

L.A. McKeown

August 07, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

Advertisement

DES Linked With Lower In-Hospital Mortality Than BMS for All PCI Indications

Antirestenotic Efficacy in the Treatment of In-Stent Restenosis: A Comparison of Two Paclitaxel Drug-Eluting Balloons With Different Coatings

A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: One Year Results of the PATENT-C First-in-Human Trial

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Approach to In-Stent Restenosis in 2014: DCB or DES?

Consensus and Take-home Messages

How Did I Treat This Case?

How Would I Treat This Case?

Case #2: A Challenging Restenosis Lesion

Consensus and Take-home Messages

How Did I Treat This Case?

How Would I Treat This Case?

Case #1: Restenosis in an Unusual Venous Bypass Bifurcated Lesion

El Impacto Clínico del Fracaso del SLF Depende del Timing

Clinical Impact of DES Failure Depends on Timing

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content